36 results on '"Kitaura, Jiro"'
Search Results
2. Positive and negative roles of lipids in mast cells and allergic responses.
- Author
-
Kitaura, Jiro and Murakami, Makoto
- Subjects
- *
MAST cells , *LIPIDS , *ARACHIDONIC acid , *EICOSAPENTAENOIC acid , *DOCOSAHEXAENOIC acid - Abstract
• Mast cell-derived cysLTs and PGD 2 are potent regulators of type 2 immunity. • Microenvironmental PGE 2 suppresses mast cell activation and allergic responses. • ω3 epoxides derived from EPA and DHA ensure optimal activation of mast cells. • The inhibitory CD300-lipid axis acts as a braking system in mast cell activation. Mast cells are a central immune cell population that are crucial in allergic responses. They secrete granule contents and cytokines and produce a panel of lipid mediators in response to FcεRI-dependent or independent stimuli. Leukotrienes and prostaglandins derived from ω6 arachidonic acid, or specialized pro-resolving lipid mediators derived from ω3 eicosapentaenoic and docosahexaenoic acids, exert pleiotropic effects on various cells in the tissue microenvironment, thereby positively or negatively regulating allergic responses. Mast cells also express the inhibitory receptors CD300a and CD300f, which recognize structural lipids. CD300a or CD300f binding to externalized phosphatidylserine or extracellular ceramides, respectively, inhibits FcεRI-mediated mast cell activation. The inhibitory CD300-lipid axis downregulates IgE-driven, mast cell-dependent type I hypersensitivity through different mechanisms. Herein, we provide an overview of our current understanding of the biological roles of lipids in mast cell-dependent allergic responses. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Mucosal Mast Cells as Key Effector Cells in Food Allergies.
- Author
-
Nakano, Nobuhiro and Kitaura, Jiro
- Subjects
- *
FOOD allergy , *MAST cells , *CONNECTIVE tissue cells , *IMMUNOGLOBULIN E , *CELL physiology , *PROGENITOR cells , *INTESTINAL mucosa - Abstract
Mucosal mast cells (MMCs) localized in the intestinal mucosa play a key role in the development of IgE-mediated food allergies. Recent advances have revealed that MMCs are a distinctly different population from connective tissue mast cells localized in skin and other connective tissues. MMCs are inducible and transient cells that arise from bone marrow-derived mast cell progenitors, and their numbers increase rapidly during mucosal allergic inflammation. However, the mechanism of the dramatic expansion of MMCs and their cell functions are not well understood. Here, we review recent findings on the mechanisms of MMC differentiation and expansion, and we discuss the potential for the inducers of differentiation and expansion to serve as targets for food allergy therapy. In addition, we also discuss the mechanism by which oral immunotherapy, a promising treatment for food allergy patients, induces unresponsiveness to food allergens and the roles of MMCs in this process. Research focusing on MMCs should provide useful information for understanding the underlying mechanisms of food allergies in order to further advance the treatment of food allergies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations.
- Author
-
Inoue, Daichi, Kitaura, Jiro, Togami, Katsuhiro, Nishimura, Koutarou, Enomoto, Yutaka, Uchida, Tomoyuki, Kagiyama, Yuki, Kawabata, Kimihito Cojin, Nakahara, Fumio, Izawa, Kumi, Oki, Toshihiko, Maehara, Akie, Isobe, Masamichi, Tsuchiya, Akiho, Harada, Yuka, Harada, Hironori, Ochiya, Takahiro, Aburatani, Hiroyuki, Kimura, Hiroshi, and Thol, Felicitas
- Subjects
- *
ANIMAL experimentation , *BIOLOGICAL models , *CELL lines , *CELL receptors , *HEMATOPOIESIS , *METHYLATION , *MICE , *GENETIC mutation , *MYELODYSPLASTIC syndromes , *PEPTIDES , *PROTEINS , *RESEARCH funding , *RNA - Abstract
Recurrent mutations in the gene encoding additional sex combs-like 1 (ASXL1) are found in various hematologic malignancies and associated with poor prognosis. In particular, ASXL1 mutations are common in patients with hematologic malignancies associated with myelodysplasia, including myelodysplastic syndromes (MDSs), and chronic myelomonocytic leukemia. Although loss-of-function ASXL1 mutations promote myeloid transformation, a large subset of ASXL1 mutations is thought to result in stable truncation of ASXL1. Here we demonstrate that C-terminal–truncating Asxl1 mutations (ASXL1-MTs) inhibited myeloid differentiation and induced MDS-like disease in mice. ASXL1-MT mice displayed features of human-associated MDS, including multi-lineage myelodysplasia, pancytopenia, and occasional progression to overt leukemia. ASXL1-MT resulted in derepression of homeobox A9 (Hoxa9) and microRNA-125a (miR-125a) expression through inhibition of polycomb repressive complex 2–mediated (PRC2-mediated) methylation of histone H3K27. miR-125a reduced expression of C-type lectin domain family 5, member a (Clec5a), which is involved in myeloid differentiation. In addition, HOXA9 expression was high in MDS patients with ASXL1-MT, while CLEC5A expression was generally low. Thus, ASXL1-MT–induced MDS-like disease in mice is associated with derepression of Hoxa9 and miR-125a and with Clec5a dysregulation. Our data provide evidence for an axis of MDS pathogenesis that implicates both ASXL1 mutations and miR-125a as therapeutic targets in MDS. [ABSTRACT FROM AUTHOR]
- Published
- 2013
5. Myelodysplastic syndromes are induced by histone methylation—altering ASXL1 mutations.
- Author
-
Inoue, Daichi, Kitaura, Jiro, Togami, Katsuhiro, Nishimura, Koutarou, Enomoto, Yutaka, Uchida, Tomoyuki, Kagiyama, Yuki, Cojin Kawabata, Kimihito, Nakahara, Fumio, Izawa, Kumi, Oki, Toshihiko, Maehara, Akie, Isobe, Masamichi, Tsuchiya, Akiho, Harada, Yuka, Harada, Hironori, Ochiya, Takahiro, Aburatani, Hiroyuki, Kimura, Hiroshi, and Thol, Felicitas
- Subjects
- *
MYELODYSPLASTIC syndromes , *HISTONE methylation , *GENETIC mutation , *FUNCTIONAL loss in older people , *MYELOID metaplasia , *METHYLATION - Abstract
Recurrent mutations in the gene encoding additional sex combs-like 1 (ASXL1) are found in various hematologic malignancies and associated with poor prognosis. In particular, ASXL1 mutations are common in patients with hematologic malignancies associated with myelodysplasia, including myelodysplastic syndromes (MDSs), and chronic myelomonocytic leukemia. Although loss-of-function ASXL1 mutations promote myeloid transformation, a large subset of ASXL1 mutations is thought to result in stable truncation of ASXL1. Here we demonstrate that C-terminal-truncating Asxl1 mutations (ASXL1-MTs) inhibited myeloid differentiation and induced MDS-like disease in mice. ASXL1-MT mice displayed features of human-associated MDS, including multilineage myelodysplasia, pancytopenia, and occasional progression to overt leukemia. ASXL1-MT resulted in derepression of homeobox A9 (Hoxa9) and microRNA-125a (miR-125a) expression through inhibition of polycomb repressive complex 2-mediated (PRC2-mediated) methylation of histone H3K27. miR-125a reduced expression of C-type lectin domain family 5, member a (Clec5a), which is involved in myeloid differentiation. In addition, HOXA9 expression was high in MDS patients with ASXL1-MT, while CLEC5A expression was generally low. Thus, ASXL1-MT-induced MDS-like disease in mice is associated with derepression of Hoxa9 and miR-125a and with Clec5a dysregulation. Our data provide evidence for an axis of MDS pathogenesis that implicates both ASXL1 mutations and miR-125a as therapeutic targets in MDS. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
6. Molecular bases of myelodysplastic syndromes: Lessons from animal models.
- Author
-
KOMENO, YUKIKO, KITAURA, JIRO, and KITAMURA, TOSHIO
- Subjects
- *
MYELODYSPLASTIC syndromes , *STEM cells , *HEMATOPOIESIS , *DYSPLASIA , *ACUTE myeloid leukemia , *GENETIC mutation , *TRANSCRIPTION factors - Abstract
Myelodysplastic syndrome (MDS) is a clonal disorder of hematopietic stem cells characterized by ineffective hematopoiesis, peripheral blood cytopenia, morphologic dysplasia, and susceptibility to acute myeloid leukemia. Several mechanisms have been suggested as causes of MDS: unbalanced chromosomal abnormalities reflecting a gain or loss of chromosomal material, point mutations of transcription factors, and inactivation of p53. However, appropriate animal models that mimic MDS have long been lacking. We recently reported a novel murine model of MDS that recapitulates trilineage dysplasia and transformation to AML. In this review, we summarize the animal models of MDS and discuss the molecular bases of MDS as well as those of leukemia and myeloproliferative disorders (MPD). J. Cell. Physiol. 219: 529–534, 2009. © 2009 Wiley-Liss, Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
7. Functional Analysis of Activating Receptor LMIR4 as a Counterpart of Inhibitory Receptor LMIR3.
- Author
-
Izawa, Kumi, Kitaura, Jiro, Yamanishi, Yoshinori, Matsuoka, Takayuki, Oki, Toshihiko, Shibata, Fumi, Kumagai, Hidetoshi, Nakajima, Hideaki, Maeda-Yamamoto, Man, Hauchins, Jeffrey P., Tybuiewicz, Victor L. J., Takai, Toshiyuki, and Kitamura, Toshio
- Subjects
- *
LEUCOCYTES , *CELLS , *GRANULOCYTES , *MACROPHAGES , *MAST cells , *BONE marrow - Abstract
The leukocyte mono-Ig-like receptor (LMIR) belongs to a new family of paired immunoreceptors. In this study, we analyzed activating receptor LMIR4/CLM-5 as a counterpart of inhibitory receptor LMIR3/CLM-1. LMIR4 is expressed in myeloid cells, including granulocytes, macrophages, and mast cells, whereas LMIR3 is more broadly expressed. The association of LMIR4 with Fc receptor-γ among immunoreceptor tyrosine- based activation motif-bearing molecules was indispensable for LMIR4-mediated functions of bone marrow-derived mast cells, but dispensable for its surface expression. Cross-linking of LMIR4 led to Lyn- and Syk-dependent activation of bone mar- row-derived mast cells, resulting in cytokine production and degranulation, whereas that of LMIR3 did not. The triggering of LMIR4 and TLR4 synergistically caused robust cytokine production in accordance with enhanced activation of ERK, whereas the co-ligation of LMIR4 and LMIR3 dramatically abrogated cytokine production. Notably, intraperitoneal administration of lipopolysaccharide strikingly up-regulated LMIR3 and down-regulated LMIR4, whereas that of granulocyte colony-stimulating factor up-regulated both LMIR3 and LMIR4 in granulocytes. Cross-linking of LMIR4 in bone marrow granulocytes also resulted in their activation, which was enhanced by lipopolysaccharide. Collectively, these results suggest that the innate immune system is at least in part regulated by the qualitative and quantitative balance of the paired receptors LMIR3 and LMIR4. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
8. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the Fc∊RI.
- Author
-
Kitaura, Jiro, Song, Jinming, Tsai, Mindy, Asai, Koichi, Maeda-Yamamoto, Man, Mocsai, Attila, Kawakami, Yuko, Liu, Fu-Tong, Lowell, Clifford A., Barisas, B. George, Galli, Stephen J., and Kawakami, Toshiaki
- Subjects
- *
IMMUNOGLOBULIN E , *MAST cells , *CYTOKINES , *PROTEIN-tyrosine kinases - Abstract
We demonstrate that binding of different IgE molecules (IgEs) to their receptor, Fc∊RI, induces a spectrum of activation events in the absence of a specific antigen and provide evidence that such activation reflects aggregation of Fc∊RI. Highly cytokinergic IgEs can efficiently induce production of cytokines and render mast cells resistant to apoptosis in an autocrine fashion, whereas poorly cytokinergic IgEs induce these effects inefficiently. Highly cytokinergic IgEs seem to induce more extensive Fc∊RI aggregation than do poorly cytokinergic IgEs, which leads to stronger mast cell activation and survival effects. These effects of both types of IgEs require Syk tyrosine kinase and can be inhibited by Fc∊RI disaggregation with monovalent hapten. In hybridoma-transplanted mice, mucosal mast cell numbers correlate with serum IgE levels. Therefore, survival effects of IgE could contribute to the pathogenesis of allergic disease. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
9. A Ras activation pathway dependent on Syk phosphorylation of protein kinase C.
- Author
-
Kawakami, Yuko and Kitaura, Jiro
- Subjects
- *
PHOSPHORYLATION , *PROTEIN kinase C - Abstract
Studies the dependence of a Ras activation pathway dependent on Syk phosphorylation of protein kinase C (PKC). Role of PKC and Syk protein tyrosine kinase in immune cell activation; PKC beta-1-Grb-2 interaction appearing to contribute to the acivation of Ras and ERK.
- Published
- 2003
- Full Text
- View/download PDF
10. Regulation of protein kinase C...I by two protein-tyrosine kinases, Btk and Syk.
- Author
-
Kawakami, Yuko and Kitaura, Jiro
- Subjects
- *
IMMUNOGLOBULIN genes , *PROTEIN-tyrosine kinases , *PROTEIN kinase C - Abstract
Describes a study which provides genetic, biochemical and pharmacological evidence that, on high-affinity immunoglobulin receptors stimulation, Syk regulates Bruton's tyrosine kinase (Btk), and Btk regulates the membrane translocation and enzymic activity of protein kinase C. Cell culture and stimulation; Immunoblotting analysis and antibodies; Results and discussion.
- Published
- 2000
- Full Text
- View/download PDF
11. Tuning IgE: IgE-Associating Molecules and Their Effects on IgE-Dependent Mast Cell Reactions.
- Author
-
Ando, Tomoaki and Kitaura, Jiro
- Subjects
- *
MAST cells , *MOLECULES , *ALLERGIES , *ASTHMA , *BASOPHILS , *TRYPTASE - Abstract
The recent emergence of anti-immunoglobulin E (IgE) drugs and their candidates for humans has endorsed the significance of IgE-dependent pathways in allergic disorders. IgE is distributed locally in the tissues or systemically to confer a sensory mechanism in a domain of adaptive immunity to the otherwise innate type of effector cells, namely, mast cells and basophils. Bound on the high-affinity IgE receptor FcεRI, IgE enables fast memory responses against revisiting threats of venoms, parasites, and bacteria. However, the dysregulation of IgE-dependent reactions leads to potentially life-threatening allergic diseases, such as asthma and anaphylaxis. Therefore, reactivity of the IgE sensor is fine-tuned by various IgE-associating molecules. In this review, we discuss the mechanistic basis for how IgE-dependent mast cell activation is regulated by the IgE-associating molecules, including the newly developed therapeutic candidates. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Ileal Crohn's Disease Exhibits Reduced Activity of Phospholipase C-β3-Dependent Wnt/β-Catenin Signaling Pathway.
- Author
-
Ando, Tomoaki, Takazawa, Ikuo, Spencer, Zachary T., Ito, Ryoji, Tomimori, Yoshiaki, Mikulski, Zbigniew, Matsumoto, Kenji, Ishitani, Tohru, Denson, Lee A., Kawakami, Yu, Kawakami, Yuko, Kitaura, Jiro, Ahmed, Yashi, and Kawakami, Toshiaki
- Subjects
- *
CROHN'S disease , *ENTERITIS , *INFLAMMATORY bowel diseases , *CATENINS , *CELLULAR signal transduction , *INTESTINAL mucosa , *PHOSPHOLIPASES - Abstract
Crohn's disease is a chronic, debilitating, inflammatory bowel disease. Here, we report a critical role of phospholipase C-β3 (PLC-β3) in intestinal homeostasis. In PLC-β3-deficient mice, exposure to oral dextran sodium sulfate induced lethality and severe inflammation in the small intestine. The lethality was due to PLC-β3 deficiency in multiple non-hematopoietic cell types. PLC-β3 deficiency resulted in reduced Wnt/β-catenin signaling, which is essential for homeostasis and the regeneration of the intestinal epithelium. PLC-β3 regulated the Wnt/β-catenin pathway in small intestinal epithelial cells (IECs) at transcriptional, epigenetic, and, potentially, protein–protein interaction levels. PLC-β3-deficient IECs were unable to respond to stimulation by R-spondin 1, an enhancer of Wnt/β-catenin signaling. Reduced expression of PLC-β3 and its signature genes was found in biopsies of patients with ileal Crohn's disease. PLC-β regulation of Wnt signaling was evolutionally conserved in Drosophila. Our data indicate that a reduction in PLC-β3-mediated Wnt/β-catenin signaling contributes to the pathogenesis of ileal Crohn's disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
- Author
-
Togami, Katsuhiro, Kitaura, Jiro, Uchida, Tomoyuki, Inoue, Daichi, Nishimura, Koutarou, Kawabata, Kimihito C., Nagase, Reina, Horikawa, Sayuri, Izawa, Kumi, Fukuyama, Tomofusa, Nakahara, Fumio, Oki, Toshihiko, Harada, Yuka, Harada, Hironori, Aburatani, Hiroyuki, and Kitamura, Toshio
- Subjects
- *
GENETIC mutation , *CCAAT enhancer binding proteins , *ACUTE myeloid leukemia , *DISEASE progression , *LEUCINE zippers - Abstract
Two types of CCAAT-enhancer-binding protein α (C/EBPα) mutants are found in acute myeloid leukemia (AML) patients: N-terminal frame-shift mutants (C/EBPα-N m ) generating p30 as a dominant form and C-terminal basic leucine zipper domain mutants (C/EBPα-C m ). We have previously shown that C/EBPα-K304_R323dup belonging to C/EBPα-C m , but not C/EBPα-T60fsX159 belonging to C/EBPα-N m , alone induced AML in mouse bone marrow transplantation (BMT) models. Here we show that various C/EBPα-C m mutations have a similar, but not identical, potential in myeloid leukemogenesis. Notably, like C/EBPα-K304_R323dup, any type of C/EBPα-C m tested (C/EBPα-S299_K304dup, K313dup, or N321D) by itself induced AML, albeit with different latencies after BMT; C/EBPα-N321D induced AML with the shortest latency. By analyzing the gene expression profiles of C/EBPα-N321D- and mock-transduced c-kit + Sca-1 + Lin − cells, we identified Csf1r as a gene downregulated by C/EBPα-N321D. In addition, leukemic cells expressing C/EBPα-C m exhibited low levels of colony stimulating factor 1 receptor in mice. On the other hand, transduction with C/EBPα-N m did not influence Csf1r expression in c-kit + Sca-1 + Lin − cells, implying a unique role for C/EBPα-C m in downregulating Csf1r . Importantly, Csf1r overexpression collaborated with C/EBPα-N321D to induce fulminant AML with leukocytosis in mouse BMT models to a greater extent than did C/EBPα-N321D alone. Collectively, these results suggest that C/EBPα-C m -mediated downregulation of Csf1r has a negative, rather than a positive, impact on the progression of AML involving C/EBPα-C m , which might possibly be accelerated by additional genetic and/or epigenetic alterations inducing Csf1r upregulation. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Hes1 upregulation contributes to the development of FIP1L1-PDGRA–positive leukemia in blast crisis.
- Author
-
Uchida, Tomoyuki, Kitaura, Jiro, Nakahara, Fumio, Togami, Katsuhiro, Inoue, Daichi, Maehara, Akie, Nishimura, Koutarou, Kawabata, Kimihito C., Doki, Noriko, Kakihana, Kazuhiko, Yoshioka, Kosuke, Izawa, Kumi, Oki, Toshihiko, Sada, Akiko, Harada, Yuka, Ohashi, Kazuteru, Katayama, Yoshio, Matsui, Toshimitsu, Harada, Hironori, and Kitamura, Toshio
- Subjects
- *
GENE expression , *GENE enhancers , *CHRONIC myeloid leukemia , *PLATELET-derived growth factor receptors , *EOSINOPHILIA , *MYELOPROLIFERATIVE neoplasms , *BONE marrow transplantation , *LABORATORY mice - Abstract
We have previously shown that elevated expression of Hairy enhancer of split 1 (Hes1) contributes to blast crisis transition in Bcr-Abl–positive chronic myelogenous leukemia. Here we investigate whether Hes1 is involved in the development of other myeloid neoplasms. Notably, Hes1 expression was elevated in only a few cases of 65 samples with different types of myeloid neoplasms. Interestingly, elevated expression of Hes1 was found in two of five samples of Fip1-like1 platelet-derived growth factor receptor-α (FIP1L1-PDGFA)-positive myeloid neoplasms associated with eosinophilia. Whereas FIP1L1-PDGFRα alone induced acute T-cell leukemia or myeloproliferative neoplasms in mouse bone marrow transplantation models, mice transplanted with bone marrow cells expressing both Hes1 and FIP1L1-PDGFRα developed acute leukemia characterized by an expansion of myeloid blasts and leukemic cells without eosinophilic granules. FIP1L1-PDGFRα conferred cytokine-independent growth to Hes1-transduced common myeloid progenitors, interleukin-3–dependent cells. Imatinib inhibited the growth of common myeloid progenitors expressing Hes1 with FIP1L1-PDGFRα, but not with imatinib-resistant FIP1L1-PDGFRα mutants harboring T674I or D842V. In contrast, ponatinib efficiently eradicated leukemic cells expressing Hes1 and the imatinib-resistant FLP1L1-PDGFRΑ mutant in vitro and in vivo. Thus, we have established mouse models of FIP1L1-PDGFRA-positive leukemia in myeloid blast crisis, which will help elucidate the pathogenesis of the disease and develop a new treatment for it. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
15. NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype.
- Author
-
Muela-Zarzuela, Inés, Suarez-Rivero, Juan Miguel, Gallardo-Orihuela, Andrea, Wang, Chun, Izawa, Kumi, de Gregorio-Procopio, Marta, Couillin, Isabelle, Ryffel, Bernhard, Kitaura, Jiro, Sanz, Alberto, von Zglinicki, Thomas, Mbalaviele, Gabriel, and Cordero, Mario D.
- Subjects
- *
INFLAMMASOMES , *CELLULAR aging , *AGING , *WESTERN immunoblotting , *PHENOTYPES , *P16 gene , *IMMUNOSENESCENCE - Abstract
Background: Senescence is a cellular aging-related process triggered by different stresses and characterized by the secretion of various inflammatory factors referred to as senescence-associated secretory phenotype (SASP), some of which are produced by the NLRP3 inflammasome. Here, we present evidence that the NLRP1 inflammasome is a DNA damage sensor and a key mediator of senescence.Senescence was induced in fibroblasts in vitro and in mice. Cellular senescence was assessed by Western blot analysis of several proteins, including p16, p21, p53, and SASP factors, released in the culture media or serum. Inflammasome components, including NLRP1, NLRP3 and GSDMD were knocked out or silenced using siRNAs.In vitro and in vivo results suggest that the NLRP1 inflammasome promotes senescence by regulating the expression of p16, p21, p53, and SASP factors in a Gasdermin D (GSDMD)-dependent manner. Mechanistically, the NLRP1 inflammasome is activated in response to genomic damage detected by the cytosolic DNA sensor cGMP-AMP (cGAMP) synthase (cGAS).Our findings show that NLRP1 is a cGAS-dependent DNA damage sensor during senescence and a mediator of SASP release through GSDMD. This study advances the knowledge on the biology of the NLRP1 inflammasome and highlights this pathway as a potential pharmcological target to modulate senescence.Methods: Senescence is a cellular aging-related process triggered by different stresses and characterized by the secretion of various inflammatory factors referred to as senescence-associated secretory phenotype (SASP), some of which are produced by the NLRP3 inflammasome. Here, we present evidence that the NLRP1 inflammasome is a DNA damage sensor and a key mediator of senescence.Senescence was induced in fibroblasts in vitro and in mice. Cellular senescence was assessed by Western blot analysis of several proteins, including p16, p21, p53, and SASP factors, released in the culture media or serum. Inflammasome components, including NLRP1, NLRP3 and GSDMD were knocked out or silenced using siRNAs.In vitro and in vivo results suggest that the NLRP1 inflammasome promotes senescence by regulating the expression of p16, p21, p53, and SASP factors in a Gasdermin D (GSDMD)-dependent manner. Mechanistically, the NLRP1 inflammasome is activated in response to genomic damage detected by the cytosolic DNA sensor cGMP-AMP (cGAMP) synthase (cGAS).Our findings show that NLRP1 is a cGAS-dependent DNA damage sensor during senescence and a mediator of SASP release through GSDMD. This study advances the knowledge on the biology of the NLRP1 inflammasome and highlights this pathway as a potential pharmcological target to modulate senescence.Results: Senescence is a cellular aging-related process triggered by different stresses and characterized by the secretion of various inflammatory factors referred to as senescence-associated secretory phenotype (SASP), some of which are produced by the NLRP3 inflammasome. Here, we present evidence that the NLRP1 inflammasome is a DNA damage sensor and a key mediator of senescence.Senescence was induced in fibroblasts in vitro and in mice. Cellular senescence was assessed by Western blot analysis of several proteins, including p16, p21, p53, and SASP factors, released in the culture media or serum. Inflammasome components, including NLRP1, NLRP3 and GSDMD were knocked out or silenced using siRNAs.In vitro and in vivo results suggest that the NLRP1 inflammasome promotes senescence by regulating the expression of p16, p21, p53, and SASP factors in a Gasdermin D (GSDMD)-dependent manner. Mechanistically, the NLRP1 inflammasome is activated in response to genomic damage detected by the cytosolic DNA sensor cGMP-AMP (cGAMP) synthase (cGAS).Our findings show that NLRP1 is a cGAS-dependent DNA damage sensor during senescence and a mediator of SASP release through GSDMD. This study advances the knowledge on the biology of the NLRP1 inflammasome and highlights this pathway as a potential pharmcological target to modulate senescence.Conclusion: Senescence is a cellular aging-related process triggered by different stresses and characterized by the secretion of various inflammatory factors referred to as senescence-associated secretory phenotype (SASP), some of which are produced by the NLRP3 inflammasome. Here, we present evidence that the NLRP1 inflammasome is a DNA damage sensor and a key mediator of senescence.Senescence was induced in fibroblasts in vitro and in mice. Cellular senescence was assessed by Western blot analysis of several proteins, including p16, p21, p53, and SASP factors, released in the culture media or serum. Inflammasome components, including NLRP1, NLRP3 and GSDMD were knocked out or silenced using siRNAs.In vitro and in vivo results suggest that the NLRP1 inflammasome promotes senescence by regulating the expression of p16, p21, p53, and SASP factors in a Gasdermin D (GSDMD)-dependent manner. Mechanistically, the NLRP1 inflammasome is activated in response to genomic damage detected by the cytosolic DNA sensor cGMP-AMP (cGAMP) synthase (cGAS).Our findings show that NLRP1 is a cGAS-dependent DNA damage sensor during senescence and a mediator of SASP release through GSDMD. This study advances the knowledge on the biology of the NLRP1 inflammasome and highlights this pathway as a potential pharmcological target to modulate senescence. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. APCCDH1 Targets MgcRacGAP for Destruction in the Late M Phase
- Author
-
Nishimura, Koutarou, Oki, Toshihiko, Kitaura, Jiro, Kuninaka, Shinji, Saya, Hideyuki, Sakaue-Sawano, Asako, Miyawaki, Atsushi, and Kitamura, Toshio
- Subjects
- *
AMMONIUM perchlorate , *TARGETED drug delivery , *GERM cells , *GTPASE-activating protein , *RHO-associated kinases , *CYTOKINESIS , *CELL cycle - Abstract
Background: Male germ cell RacGTPase activating protein (MgcRacGAP) is an important regulator of the Rho family GTPases — RhoA, Rac1, and Cdc42 — and is indispensable in cytokinesis and cell cycle progression. Inactivation of RhoA by phosphorylated MgcRacGAP is an essential step in cytokinesis. MgcRacGAP is also involved in G1-S transition and nuclear transport of signal transducer and activator of transcription 3/5 (STAT3/5). Expression of MgcRacGAP is strictly controlled in a cell cycle-dependent manner. However, the underlying mechanisms have not been elucidated. Methodology/Principal Findings: Using MgcRacGAP deletion mutants and the fusion proteins of full-length or partial fragments of MgcRacGAP to mVenus fluorescent protein, we demonstrated that MgcRacGAP is degraded by the ubiquitin-proteasome pathway in the late M to G1 phase via APCCDH1. We also identified the critical region for destruction located in the C-terminus of MgcRacGAP, AA537–570, which is necessary and sufficient for CDH1-mediated MgcRacGAP destruction. In addition, we identified a PEST domain-like structure with charged residues in MgcRacGAP and implicate it in effective ubiquitination of MgcRacGAP. Conclusions/Significance: Our findings not only reveal a novel mechanism for controlling the expression level of MgcRacGAP but also identify a new target of APCCDH1. Moreover our results identify a C-terminal region AA537–570 of MgcRacGAP as its degron. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
17. Protein Kinase C βII Regulates Akt Phosphorylation on Ser-473 in a Cell Type- and Stimulus-specific Fashion.
- Author
-
Kawakami, Yuko, Nishimoto, Hajime, Kitaura, Jiro, Maeda-yamamoto, Man, Katoh, Roberta M., Littman, Dan R., Rawlings, David J., and Kawakami, Toshiaki
- Subjects
- *
PROTEIN kinase C , *PROTEIN kinases , *PHOSPHOTRANSFERASES , *PHOSPHORYLATION , *CHEMICAL reactions , *CELL membranes - Abstract
Akt (= protein kinase B), a subfamily of the AGC serine/threonine kinases, plays critical roles in survival, proliferation, glucose metabolism, and other cellular functions. Akt activation requires the recruitment of the enzyme to the plasma membrane by interacting with membrane-bound lipid products of phosphatidylinositol 3-kinase. Membrane-bound Akt is then phosphorylated at two sites for its full activation; Thr-308 in the activation loop of the kinase domain is phosphorylated by 3-phosphoinositide-dependent kinase-1 (PDK1) and Ser473 in the C-terminal hydrophobic motif by a putative kinase PDK2. The identity of PDK2 has been elusive. Here we present evidence that conventional isoforms of protein kinase C (PKC), particularly PKCβII, can regulate Akt activity by directly phosphorylating Ser-473 in vitro and in IgE/antigen-stimulated mast cells. By contrast, PKCβ is not required for Ser-473 phosphorylation in mast cells stimulated with stem cell factor or interleukin-3, in serum-stimulated fibroblasts, or in antigen receptor-stimulated T or B lymphocytes. Therefore, PKCβII appears to work as a cell type- and stimulusspecific PDK2. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
18. Protein Kinase Cβ (PKCβ): Nomal Functions and Dieases.
- Author
-
Kawakami, Toshiaki, Kawakami, Yuko, and Kitaura, Jiro
- Published
- 2002
- Full Text
- View/download PDF
19. Orally desensitized mast cells form a regulatory network with Treg cells for the control of food allergy.
- Author
-
Takasato, Yoshihiro, Kurashima, Yosuke, Kiuchi, Masahiro, Hirahara, Kiyoshi, Murasaki, Sayuri, Arai, Fujimi, Izawa, Kumi, Kaitani, Ayako, Shimada, Kaoru, Saito, Yukari, Toyoshima, Shota, Nakamura, Miho, Fujisawa, Kumiko, Okayama, Yoshimichi, Kunisawa, Jun, Kubo, Masato, Takemura, Naoki, Uematsu, Satoshi, Akira, Shizuo, and Kitaura, Jiro
- Published
- 2021
- Full Text
- View/download PDF
20. Anti-CD321 antibody immunotherapy protects liver against ischemia and reperfusion-induced injury.
- Author
-
Yin, Enzhi, Fukuhara, Takeshi, Takeda, Kazuyoshi, Kojima, Yuko, Fukuhara, Kyoko, Ikejima, Kenichi, Bashuda, Hisashi, Kitaura, Jiro, Yagita, Hideo, Okumura, Ko, and Uchida, Koichiro
- Subjects
- *
IMMUNOTHERAPY , *ISCHEMIA , *LIVER transplantation , *T cells , *LIVER enzymes - Abstract
The prognosis of the liver transplant patients was frequently deteriorated by ischemia and reperfusion injury (IRI) in the liver. Infiltration of inflammatory cells is reported to play critical roles in the pathogenesis of hepatic IRI. Although T lymphocytes, neutrophils and monocytes infiltrated into the liver underwent IRI, we found that neutrophil depletion significantly attenuated the injury and serum liver enzyme levels in a murine model. Interestingly, the expression of CD321/JAM-A/F11R, one of essential molecules for transmigration of circulating leukocytes into inflammatory tissues, was significantly augmented on hepatic sinusoid endothelium at 1 h after ischemia and maintained until 45 min after reperfusion. The intraportal administration of anti-CD321 monoclonal antibody (90G4) significantly inhibited the leukocytes infiltration after reperfusion and diminished the damage responses by hepatic IRI (serum liver enzymes, inflammatory cytokines and hepatocyte cell death). Taken together, presented results demonstrated that blockade of CD321 by 90G4 antibody significantly attenuated hepatic IRI accompanied with substantial inhibition of leukocytes infiltration, particularly inhibition of neutrophil infiltration in the early phase of reperfusion. Thus, our work offers a potent therapeutic target, CD321, for preventing liver IRI. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. CD300f is a potential therapeutic target for the treatment of food allergy.
- Author
-
Uchida, Shino, Izawa, Kumi, Ando, Tomoaki, Yamada, Hiromichi, Uchida, Koichiro, Negishi, Naoko, Kaitani, Ayako, Maehara, Akie, Nagamine, Masakazu, Kamei, Anna, Takamori, Ayako, Maeda, Keiko, Nakano, Nobuhiro, Shimizu, Toshiaki, Ogawa, Hideoki, Okumura, Ko, Nagahara, Akihito, Watanabe, Sumio, and Kitaura, Jiro
- Subjects
- *
FOOD allergy , *OVALBUMINS , *SUPPRESSOR cells - Abstract
The interaction between CD300f and its ligand ceramide suppresses IgE-mediated mast cell activation and anaphylactic responses through phosphorylation of immunoreceptor tyrosine-based inhibitory and switch motifs.[2] CD300f also regulates gut inflammation by different mechanisms.[[3]] Nevertheless, it remains unknown whether CD300f regulates the development of food allergy. Serum levels of total IgE (C), OVA-specific IgE (D) and MCPT-1 (E), and the numbers of jejunum mast cells (F) in WT and CD300f-/- (KO) mice after the last challenge. According to numerous studies, Tregs inhibit both Th2 skewing, involving food antigen-specific IgE production and IL-9-mediated mast cell hyperplasia, and IgE/antigen-mediated mast cell activation, which are pivotal in the development of food allergy, whereas Th2- and mast cell-derived cytokines (eg, IL-4) downregulate Tregs.[[1], [6], [9]] Accordingly, CD300f in intestinal mast cells (possibly in concert with CD103 SP + sp CD11b SP + sp cells) inhibits the development of OVA-induced food allergy by suppressing mast cell activation with the skewing of Th2/Treg balance toward Th2. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
22. Mouse LIMR3/CD300f is a negative regulator of the antimicrobial activity of neutrophils.
- Author
-
Ueno, Keigo, Urai, Makoto, Izawa, Kumi, Otani, Yoshiko, Yanagihara, Nao, Kataoka, Michiyo, Takatsuka, Shogo, Abe, Masahiro, Hasegawa, Hideki, Shimizu, Kiminori, Kitamura, Toshio, Kitaura, Jiro, Miyazaki, Yoshitsugu, and Kinjo, Yuki
- Published
- 2018
- Full Text
- View/download PDF
23. The Phosphatidylserine and Phosphatidylethanolamine Receptor CD300a Binds Dengue Virus and Enhances Infection.
- Author
-
Carnec, Xavier, Meertens, Laurent, Dejarnac, Ophélie, Perera-Lecoin, Manuel, Hafirassou, Mohamed Lamine, Kitaura, Jiro, Ramdasi, Rasika, Schwartz, Olivier, and Amara, Ali
- Subjects
- *
PHOSPHATIDYLSERINES , *PHOSPHATIDYLETHANOLAMINES , *DENGUE viruses , *INFECTION , *PHAGOCYTOSIS - Abstract
Dengue virus (DENV) is the etiological agent of the major human arboviral disease. We previously demonstrated that the TIM and TAM families of phosphatidylserine (PtdSer) receptors involved in the phagocytosis of apoptotic cells mediate DENV entry into target cells. We show here that human CD300a, a recently identified phospholipid receptor, also binds directly DENV particles and enhances viral entry. CD300a facilitates infection of the four DENV serotypes, as well as of other mosquito-borne viruses such as West Nile virus and Chikungunya virus. CD300a acts as an attachment factor that enhances DENV internalization through clathrin-mediated endocytosis. CD300a recognizes predominantly phosphatidylethanolamine (PtdEth) and to a lesser extent PtdSer associated with viral particles. Mutation of residues in the IgV domain critical for phospholipid binding abrogate CD300a-mediated enhancement of DENV infection. Finally, we show that CD300a is expressed at the surface of primary macrophages and anti-CD300a polyclonal antibodies partially inhibited DENV infection of these cells. Overall, these data indicate that CD300a is a novel DENV binding receptor that recognizes PtdEth and PtdSer present on virions and enhance infection. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
24. Human CD300C Delivers an Fc Receptor-γ-dependent Activating Signal in Mast Cells and Monocytes and Differs from CD300A in Ligand Recognition.
- Author
-
Takahashi, Mariko, Izawa, Kumi, Kashiwakura, Jun-ichi, Yamanishi, Yoshinori, Enomoto, Yutaka, Kaitani, Ayako, Maehara, Akie, Isobe, Masamichi, Ito, Shinichi, Matsukawa, Toshihiro, Nakahara, Fumio, Oki, Toshihiko, Kajikawa, Masunori, Ra, Chisei, Okayama, Yoshimichi, Kitamura, Toshio, and Kitaura, Jiro
- Subjects
- *
MONOCYTES , *MAST cells , *IMMUNOGLOBULINS , *CHEMOKINES , *CYTOKINES - Abstract
D300C is highly homologous with an inhibitory receptor CD300A in an immunoglobulin-like domain among the human CD300 family of paired immune receptors. To clarify the precise expression and function of CD300C, we generated antibodies discriminating between CD300A and CD300C, which recognized a unique epitope involving amino acid residues CD300A(F56-L57) and CD300C(L63-R64). Notably, CD300C was highly expressed in human monocytes and mast cells. Cross-linking of CD300C by its specific antibody caused cytokine/ chemokine production of human monocytes and mast cells. Fc receptor γ was indispensable for both efficient surface expression and activating functions of CD300C. To identify a ligand for CD300A or CD300C, we used reporter cell lines expressing a chimera receptor harboring extracellular CD300A or CD300C and intracellular CD3ζ, in which its unknown ligand induced GFP expression. Our results indicated that phosphatidylethanolamine (PE) among the lipids tested and apoptotic cells were possible ligands for both CD300C and CD300A. PE and apoptotic cells more strongly inducedGFPexpression in the reporter cells through binding to extracellular CD300A as compared with CD300C. Differential recognition of PE by extracellular CD300A and CD300C depended on different amino acid residues CD300A(F56-L57) and CD300C(L63-R64). Interestingly, GFP expression induced by extracellular CD300C-PE binding in the reporter cells was dampened by co-expression of full-length CD300A, indicating the predominance of CD300A over CD300C in PE recognition/signaling. PE consistently failed to stimulate cytokine production in monocytes expressing CD300C with CD300A. In conclusion, specific engagement of CD300C led to Fc receptor γ-dependent activation of mast cells and monocytes. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
25. The Receptor LMIR3 Negatively Regulates Mast Cell Activation and Allergic Responses by Binding to Extracellular Ceramide
- Author
-
Izawa, Kumi, Yamanishi, Yoshinori, Maehara, Akie, Takahashi, Mariko, Isobe, Masamichi, Ito, Shinichi, Kaitani, Ayako, Matsukawa, Toshihiro, Matsuoka, Takayuki, Nakahara, Fumio, Oki, Toshihiko, Kiyonari, Hiroshi, Abe, Takaya, Okumura, Ko, Kitamura, Toshio, and Kitaura, Jiro
- Subjects
- *
CELL receptors , *MAST cells , *ALLERGIES , *CERAMIDES , *LEUCOCYTES , *IMMUNOGLOBULINS , *LABORATORY mice - Abstract
Summary: Mast cells (MCs) are key effector cells in allergic reactions. However, the inhibitory mechanism that prevents excessive activation of MCs remains elusive. Here we show that leukocyte mono-immunoglobulin-like receptor 3 (LMIR3; also called CD300f) is a negative regulator of MC activation in vivo. LMIR3 deficiency exacerbated MC-dependent allergic responses in mice, including anaphylaxis, airway inflammation, and dermatitis. Both physical binding and functional reporter assays via an extracellular domain of LMIR3 showed that several extracellular lipids (including ceramide) and lipoproteins were possible ligands for LMIR3. Importantly, MCs were frequently surrounded by extracellular ceramide in vivo. Upon engagement of high-affinity immunoglobulin E receptor, extracellular ceramide-LMIR3 binding inhibited MC activation via immunoreceptor tyrosine-based inhibitory and switch motifs of LMIR3. Moreover, pretreatment with LMIR3-Fc fusion protein or antibody against either ceramide or LMIR3 interfered with this binding in vivo, thereby exacerbating passive cutaneous anaphylaxis. Thus, the interaction between extracellular ceramide and LMIR3 suppressed MC-dependent allergic responses. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
26. PRAT4A-dependent expression of cell surface TLR5 on neutrophils, classical monocytes and dendritic cells.
- Author
-
Shibata, Takuma, Takemura, Naoki, Motoi, Yuji, Goto, Yoshiyuki, Karuppuchamy, Thangaraj, Izawa, Kumi, Li, Xiaobing, Akashi-Takamura, Sachiko, Tanimura, Natsuko, Kunisawa, Jun, Kiyono, Hiroshi, Akira, Shizuo, Kitamura, Toshio, Kitaura, Jiro, Uematsu, Satoshi, and Miyake, Kensuke
- Subjects
- *
GENE expression , *NEUTROPHILS , *MONOCYTES , *DENDRITIC cells , *NATURAL immunity , *IMMUNE response , *CELLULAR immunity - Abstract
AbstractToll-like receptor 5 (TLR5), a sensor for bacterial flagellin, mounts innate and adaptive immune responses, and has been implicated in infectious diseases, colitis and metabolic syndromes. Although TLR5 is believed to belong to cell surface TLRs, cell surface expression has never been verified. Moreover, it has remained unclear which types of immune cells express TLR5 and contribute to flagellin-dependent responses. In this study we established an anti-mouse TLR5 monoclonal antibody and studied the cell surface expression of TLR5 on immune cells. The macrophage cell line J774 expressed endogenous TLR5 on the cell surface and produced IL-6 and G-CSF in response to flagellin. Cell surface expression of TLR5 and flagellin-induced responses were completely abolished by silencing a TLR-specific chaperone protein associated with TLR4 A (PRAT4A), demonstrating that TLR5 is another client of PRAT4A. In the in vivo immune cells, cell surface TLR5 was mainly found on neutrophils and CD11bhiLy6Chi classical monocytes in the bone marrow, circulation, spleen and inflammatory lesions. Ly6Chi classical monocytes, but not neutrophils, produced cytokines in response to flagellin. Splenic CD8−CD4+ conventional dendritic cells and CD11chiCD11bhi lamina propria DCs, also clearly expressed cell surface TLR5. Collectively, cell surface expression of TLR5 is dependent on PRAT4A and restricted to neutrophils, classical monocytes and specific DC subsets. [ABSTRACT FROM PUBLISHER]
- Published
- 2012
- Full Text
- View/download PDF
27. A Soluble Form of LMIR5/CD300b Amplifies Lipopolysaccharide-Induced Lethal Inflammation in Sepsis.
- Author
-
Yamanishi, Yoshinori, Takahashi, Mariko, Izawa, Kumi, Isobe, Masamichi, Ito, Shinichi, Tsuchiya, Akiho, Maehara, Akie, Kaitani, Ayako, Uchida, Tomoyuki, Togami, Katsuhiro, Enomoto, Yutaka, Nakahara, Fumio, Oki, Toshihiko, Kajikawa, Masunori, Kurihara, Hiroki, Kitamura, Toshio, and Kitaura, Jiro
- Subjects
- *
SEPSIS , *LEUCOCYTES , *CD antigens , *LIPOPOLYSACCHARIDES , *INFLAMMATION , *REPERFUSION injury , *LABORATORY mice , *IMMUNOLOGY - Abstract
Leukocyte mono-Ig-like receptor 5 (LMIR5, also called CD300bJ is an activating receptor expressed in myeloid cells. We have previously demonstrated that T cell Ig mucin 1 works as a ligand for LMIR5 in mouse ischemia/reperfusion injury of the kidneys. In this article, we show that LMIR5 is implicated in LPS-induced sepsis in mice. Notably, neutrophils constitutively released a soluble form of LMIR5 (sLMIR5) through proteolytic cleavage of surface LMIR5. Stimulation with TLR agonists augmented the release of sLMIR5. LPS administration or peritonitis induction increased serum levels of sLMIR5 in mice, which was substantially inhibited by neutrophil depletion. Thus, neutrophils were the main source of LPS-induced sLMIR5 in vivo. On the other hand, i.p. administration of LMIR5-Fc, a surrogate of sLMIR5, bound to resident macrophages (M&phgr;) and stimulated transient inflammation in mice. Consistently, LMIR5-Fc induced in vitro cytokine production of peritoneal M&phgr; via its unknown ligand. Interestingly, LMIR5 deficiency profoundly reduced systemic cytokine production and septic mortality in LPS-administered mice, although it did not affect in vitro cytokine production of LPS-stimulated peritoneal M&phgr;. Importantly, the resistance of LMIR5-deficient mice to LPS- or peritonitis-induced septic death was decreased by LMIR5-Fc administration, implicating sLMIR5 in LPS responses in vivo. Collectively, neutrophil-derived sLMIR5 amplifies LPS-induced lethal inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
28. Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy.
- Author
-
Kashiwakura, Jun-ichi, Ando, Tomoaki, Matsumoto, Kenji, Kimura, Miho, Kitaura, Jiro, Matho, Michael H., Zajonc, Dirk M., Ozeki, Tomomitsu, Ra, Chisei, MacDonald, Susan M., Siraganian, Reuben P., Broide, David H., Kawakami, Yuko, and Kawakami, Toshiaki
- Subjects
- *
MAST cells , *BASOPHILS , *ASTHMA , *HISTAMINE , *TUMOR proteins - Abstract
IgE-mediated activation of mast cells and basophils underlies allergic diseases such as asthma. Histamine-releasing factor (HRF; also known as translationally controlled tumor protein [TCTP] and fortilin) has been implicated in late-phase allergic reactions (LPRs) and chronic allergic inflammation, but its functions during asthma are not well understood. Here, we identified a subset of IgE and IgG antibodies as HRF-interacting molecules in vitro. HRF was able to dimerize and bind to Igs via interactions of its N-terminal and internal regions with the Fab region of Igs. Therefore, HRF together with HRF-reactive IgE was able to activate mast cells in vitro. In mouse models of asthma and allergy, Ig-interacting HRF peptides that were shown to block HRF/Ig interactions in vitro inhibited IgE/HRF-induced mast cell activation and in vivo cutaneous anaphylaxis and airway inflammation. Intranasally administered HRF recruited inflammatory immune cells to the lung in naive mice in a mast cell-- and Fc receptor--dependent manner. These results indicate that HRF has a proinflammatory role in asthma and skin immediate hypersensitivity, leading us to suggest HRF as a potential therapeutic target. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
29. Characterization of Leukocyte Mono-immunoglobulin-like Receptor 7 (LMIR7)/CLM-3 as an Activating Receptor.
- Author
-
Enomoto, Yutaka, Yamanishi, Yoshinori, Izawa, Kumi, Kaitani, Ayako, Takahashi, Mariko, Maehara, Akie, Oki, Toshihiko, Takamatsu, Reiko, Kajikawa, Masunori, Takai, Toshiyuki, Kitamura, Toshio, and Kitaura, Jiro
- Subjects
- *
IMMUNOGLOBULINS , *LEUCOCYTES , *AMINO acid sequence , *FLOW cytometry , *NEUTROPHILS , *MAST cells - Abstract
Here we characterize leukocyte mono-Ig-like receptor 7 (LMIR7)/CLM-3 and compare it with an activating receptor, LMIR4/CLM-5, that is a counterpart of an inhibitory receptor LMIR3/CLM-1. LMIR7 shares high homology with LMIR4 in the amino acid sequences of its Ig-like and transmembrane domains. Flow cytometric analysis demonstrated that LMIR4 was predominantly expressed in neutrophils, whereas LMIR7 was highly expressed in mast cells and monocytes/macrophages. Importantly, LMIR7 engagement induced cytokine production in bone marrow-derived mast cells (BMMCs). Although FcRγ deficiency did not affect surface expression levels of LMIR7, it abolished LMIR7-mediated activation of BMMCs. Consistently we found significant interaction of LMIR7-FcRγ, albeit with lower affinity compared with that of LMIR4-FcRγ. Our results showed that LMIR7 transmits an activating signal through interaction with FcRγ. In addition, like LMIR4, LMIR7 synergizes with TLR4 in signaling. Analysis of several chimera receptors composed of LMIR4 and LMIR7 revealed these findings: 1) the transmembrane of LMIR7 with no charged residues maintained its surface expression at high levels in the absence of FcRγ, 2) the extracellular juxtamembrane region of LMIR7 had a negative effect on its surface expression levels; and 3) the strong interaction of LMIR4 with FcRγ depended on the extracellular juxtamembrane region as well as the transmembrane domain of LMIR4. Thus, LMIR7 shares similarities with LMIR4, although they are differentially regulated in their distribution, expression, and function. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
30. Evidence That Integrin αllbβ3-dependent Interaction of Mast Cells with Fibrinogen Exacerbates Chronic lnflammation.
- Author
-
Oki, Toshihiko, Eto, Koji, lzawa, Kumi, Yamanishi, Yoshinori, Inagaki, Naoki, Frampton, Jon, Kitamura, Toshio, and Kitaura, Jiro
- Subjects
- *
MAST cells , *INTEGRINS , *MEGAKARYOCYTES , *BONE marrow cells , *CELL proliferation , *CYTOKINES , *IMMUNE response , *STAPHYLOCOCCUS aureus - Abstract
Integrin αIIbβ3 is expressed in mast cells as well as in megakaryocytes/platelets. A recent study has shown that surface expression levels of integrin αVβ3 are elevated in integrin αIIb-deficient bone marrow-derived mast cells (BMMCs) as compared with wild-type (WT) counterparts, but the underlying mechanism remains obscure. Here we demonstrate by transducing integrin αllb into integrin αIIb-deficient BMMCs that surface expression levels of integrin αVβ3 are inversely related to those of integrin αIIbβ3. Thus, competitive association of integrin β3 with integrin αllb or integrin αV determines surface expression levels of integrin αIIbβ3 or αVβ3 in mast cells. We compared WT and integrin αlIb-deficient BMMCs as well as integrin αlIb-deficient BMMCs transduced with integrin αIIb(WT) or non-functional αlIb(D163A) mutant and found that enhancement of proliferation, degranulation, cytokine production, and migration of BMMCs through interaction with fibrinogen (FB) depended on integrin αIIbβ3. In addition, elevated surface expression of integrin αVβ3 failed to compensate for loss of FB-associated functions in integrin αIIb-deficient BMMCs while enhancing adhesion to vitronectin or von Willebrand factor. Importantly, integrin αlIb deficiency strongly suppressed chronic inflammation with the remarkable increase of mast cells induced by continuous intraperitoneal administration of FB, although it did not affect acute allergic responses or mast cell numbers in tissues in steady states. Interestingly, soluble FB promoted cytokine production of BMMCs in response to Staphylococcus aureus with FB-binding capacity, through integrin αIIbβ3-dependent recognition of this pathogen. Collectively, integrin αIIbβ3 in mast cells plays an important part in FB-associated, chronic inflammation and innate immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
31. Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.
- Author
-
Fujimoto, Keiichi, Uchida, Koichiro, Yin, Enzhi, Zhu, Jun, Kojima, Yuko, Uchiyama, Masateru, Yamamoto, Yasuto, Bashuda, Hisashi, Matsumoto, Ryu, Tokushige, Koji, Harada, Masaki, Inomata, Takenori, Kitaura, Jiro, Murakami, Akira, Okumura, Ko, and Takeda, Kazuyoshi
- Abstract
Myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) are attractive immune cells to induce immune tolerance. To explore a strategy for improving the efficacy of MDSC therapies, we examined the impact of adoptive transfer of several types of MDSCs on graft rejection in a murine heart transplantation model. We analyzed the effects of induced syngeneic and allogeneic bone marrow-derived MDSCs (BM-MDSCs) on graft survival and suppressive capacity. We also compared the ability of syngeneic monocytic MDSCs (Mo-MDSCs) and polymorphonuclear MDSCs (PMN-MDSCs) to inhibit graft rejection and investigated the suppression mechanisms. Both syngeneic and allogeneic donor- or allogeneic third-party-derived BM-MDSCs prolonged graft survival, although syngeneic BM-MDSCs inhibited anti-donor immune responses most effectively in vitro. Syngeneic Mo-MDSCs, rather than PMN-MDSCs, were responsible for immune suppression through downregulating inducible nitric oxide synthase (iNOS) and expanded naturally occurring thymic originated Treg (nTreg) in vitro. Adoptive transfer of Mo-MDSCs, but not PMN-MDSCs, prolonged graft survival and increased Treg infiltration into the graft heart. Recipient-derived Mo-MDSCs are most effective in prolonging graft survival via inhibiting T cell response and nTreg infiltration. • BM-MDSCs from recipient exert potent immune suppressive function. • Mo-MDSCs, rather than PMN-MDSCs, were the major subsets in the induced BM-MDSCs and inhibited naïve T cell activation through iNOS dependent pathway. • nTregs were expanded in the presence of Mo-MDSCs. • Mo-MDSCs infusion prolonged graft survival in a murine heart transplantation model. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
32. Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3.
- Author
-
Kawakami, Yuko, Inagaki, Naoki, Salek-Ardakani, Shahram, Kitaura, Jiro, Tanaka, Hiroyuki, Nagao, Koichi, Yu Kawakami, Wenbin Xiao, Nagai, Hiroichi, Croft, Michael, and Kawakami, Toshiaki
- Subjects
- *
DENDRITIC cells , *PROTEIN-tyrosine kinases , *INTERLEUKIN-10 , *T cells , *IMMUNOGLOBULIN E , *ASTHMA - Abstract
Btk plays crucial roles in the differentiation and activation of B and myeloid cells. Despite drastic reductions of other Ig isotypes, paradoxically high IgE responses have been known in btk mutant mice. Here we show that btk-/- dendritic cells exhibit a more mature phenotype and a stronger in vitro and in vivo T cell- stimulatory ability than wild-type cells. Increased IgE responses were induced by adoptive transfer of btk-/- dendritic cells into mice. Consistent with the stronger T cell-stimulatory ability of btk-/- dendritic cells, btk-/- mice exhibited enhanced inflammation in Th2-driven asthma and Th1-driven contact sensitivity experiments. These negative regulatory functions of Btk in dendritic cells appear to be mediated mainly through autocrine secretion of IL-10 and subsequent activation of Stat3. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
33. PKCß modulates antigen receptor signaling via regulation of Btk membrane localization.
- Author
-
Kang, Shin W., Wahl, Matthew I., Chu, Julia, Kitaura, Jiro, Kawakami, Yuko, Kato, Roberta M., Tabuchi, Ruby, Tarakhovsky, Alexander, Kawakami, Toshiaki, Turck, Christoph W., Witte, Owen N., and Rawlings, David J.
- Subjects
- *
AGAMMAGLOBULINEMIA , *PROTEIN kinases , *AMINO acids , *PROTEIN-tyrosine kinases , *IMMUNITY , *IMMUNODEFICIENCY - Abstract
Mutations in Bruton's tyrosine kinase (Btk) result in X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (xid) in mice. While targeted disruption of the protein kinase C-β (PKCβ) gene in mice results in an immunodeficiency similar to xid, the overall tyrosine phosphorylation of Btk is significantly enhanced in PKCβ-deficient B cells. We provide direct evidence that PKCβ acts as a feedback loop inhibitor of Btk activation. Inhibition of PKCβ results in a dramatic increase in B-cell receptor (BCR)-mediated Ca2+ signaling. We identified a highly conserved PKCβ serine phosphorylation site in a short linker within the Tec homology domain of Btk. Mutation of this phosphorylation site led to enhanced tyrosine phosphorylation and membrane association of Btk, and augmented BCR and Fc∊RI-mediated signaling in B and mast cells, respectively. These findings provide a novel mechanism whereby reversible translocation of Btk/Tec kinases regulates the threshold for immunoreceptor signaling and thereby modulates lymphocyte activation. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
34. The Fab fragment of anti-IgE Cε2 domain prevents allergic reactions through interacting with IgE-FcεRIα complex on rat mast cells.
- Author
-
Hirano, Takao, Koyanagi, Akemi, Kotoshiba, Kaoru, Shinkai, Yoichi, Kasai, Masataka, Ando, Tomoaki, Kaitani, Ayako, Okumura, Ko, and Kitaura, Jiro
- Abstract
Immunoglobulin E (IgE) plays a central role in the pathogenesis of Type I hypersensitivity through interaction with a high-affinity receptor (FcεRIα). For therapeutic applications, substantial attention has been focused recently on the blockade of the IgE interaction with FcεRIα. While exploring better options for preventing allergic diseases, we found that the Fab fragment of the rat anti-murine IgE antibody (Fab-6HD5) strongly inhibited passive cutaneous anaphylaxis (PCA) in vivo, as well as spleen tyrosine kinase (Syk) activity and β-hexosaminidase release from basophilic leukemia cells in vitro. The in vivo effects of Fab-6HD5 pre-administration were maintained over a long period of time for at least 10 days. Using flow cytometry analysis, we also found that Fab-6HD5 did not recognize the IgE Cε3 domain containing specific binding sites for FcεRIα. Furthermore, deletion-mapping studies revealed that Fab-6HD5 recognized conformational epitopes on the Cε2 domain of IgE. Given that the Cε2 domain plays a key role in stabilizing the interaction of IgE with FcRIα, our results suggest that the specific binding of Fab-6HD5 to the Cε2 domain prevents allergic reactions through destabilizing the preformed IgE-FcεRIα complex on rat mast cells. Although the present study was performed using animal models, these findings support the idea that a certain antibody directed against IgE CH domains may contribute to preventing allergic diseases through interacting with IgE-FcεRIα complex. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
35. Higher expression of ATP-binding cassette transporter G2 (ABCG2) is specific to advanced MDS and promotes inefficient hematopiesis via conversions of tumor microenvironments in mouse bone marrow transplantation model.
- Author
-
Kawabata, Kimihito Cojin, Hayashi, Yasutaka, Inoue, Daichi, Mizuno, Hiroki, Kitaura, Jiro, Tanaka, Yosuke, Goyama, Susumu, Harada, Yuka, Harada, Hironori, Aburatani, Hiroyuki, Ishii, Masaru, and Kitamura, Toshio
- Subjects
- *
ATP-binding cassette transporters , *BONE marrow transplantation , *NEOPLASTIC cell transformation , *ANTINEOPLASTIC agents , *MICROARRAY technology - Published
- 2016
- Full Text
- View/download PDF
36. Inactivation of EZH2 by trancated form mutaion de-represses novel target genes to promote tumor-initiating capacity.
- Author
-
Kawabata, Kimihito Cojin, Inoue, Daichi, Goyama, Susumu, Harada, Hironori, Kitaura, Jiro, and Kitamura, Toshio
- Subjects
- *
DNA , *DOMINANCE (Genetics) , *HEMATOPOIETIC stem cells , *PROGENITOR cells , *BONE marrow , *HEMATOPOIETIC system , *HEMATOPOIESIS , *HEMATOLOGY - Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.